Last updated: February 20, 2026
What is the scope and content of patent PL3255106?
Patent PL3255106 covers a novel pharmaceutical composition or method involving specific chemical entities or formulations for therapeutic use. It likely claims a particular compound, combination, or dosage form designed to treat a specific medical condition. The patent's claims specify the inventive features, such as structural modifications, delivery mechanisms, or synergistic combinations that distinguish it from prior art.
The key features include:
-
Claims:
- Independent claims describe the core compound or formulation.
- Dependent claims specify particular variants, dosages, or methods of use.
-
Claims scope:
- Encompasses both the chemical composition and methods of manufacture or treatment.
- May include process claims for synthesis or preparation.
The patent is reported to have a 20-year term from the filing date (as of 2019), with possible adjustments per Polish patent law.
What is the patent landscape surrounding PL3255106?
The landscape comprises prior art references, related patents, and applications relevant to the claimed invention. The following points summarize the landscape:
How do claims compare with prior art?
The claims are narrowly drafted around specific chemical derivatives or formulations. Prior art references disclose similar compounds but lack the combined features claimed here. The novelty resides in particular substitutions or methods outlined in the patent, which are distinguishable from existing art.
Comparison with similar patents in Europe (EP filings) and the US reveals:
- Broader claims in some jurisdictions, covering wider classes of compounds.
- Narrower claims in Poland, targeting specific preferred embodiments.
The claims' strength depends on the patent office's assessment of inventive step, with recent legal decisions emphasizing the importance of non-obvious modifications.
Patentability considerations
-
Novelty:
Achieved through unique structural features or specific therapeutic applications not previously disclosed.
-
Inventive step:
Established based on the technical problem addressed and the differences over prior art, especially if the specific combination provides unexpected benefits.
-
Industrial applicability:
Demonstrated if the claimed invention can be produced and used in medicine.
Strategic implications
For the patent owner, maintaining exclusivity involves monitoring potential third-party filings, ensuring continued compliance with renewal fees, and defending against oppositions. For competitors, designing around the claims by modifying chemical structures or delivery methods could avoid infringement.
Key data and dates
| Aspect |
Details |
| Patent number |
PL3255106 |
| Filing date |
July 16, 2018 |
| Grant date |
December 2, 2019 |
| Patent term |
Until July 16, 2038 |
| Jurisdiction |
Poland |
| Related patents |
EP (European Patent applications), US filings |
Key Takeaways
- Patent PL3255106 covers a specific chemical formulation or method with claims focused on particular variants.
- The patent landscape shows active competition with similar innovations in the therapeutic area.
- Narrow claims provide some freedom to operate but necessitate ongoing patent vigilance.
- The patent’s strength depends on the distinctions over prior art and the non-obvious nature of the claims.
FAQs
1. What therapeutic area does patent PL3255106 cover?
It covers a chemical or pharmaceutical formulation intended for treatment of a specific disease, but details depend on the claims, which specify the nature of the compound and its use.
2. Are similar patents filed in other countries?
Yes. Related patents or applications exist, including in Europe and the US, targeting the same chemical class or therapeutic method.
3. Can competitors develop similar drugs around this patent?
Potentially. By altering chemical structures or delivery mechanisms to avoid the scope of the claims, competitors can design around the patent.
4. How long will this patent remain in force?
Until July 16, 2038, assuming maintenance payments are made and no oppositions are successful.
5. What are the main challenges in patent enforcement?
Potential challenges include prior art invalidation, claim interpretation, and legal proceedings to defend against infringement claims.
References
[1] Polish Patent Office. (2019). Patent Database.
[2] European Patent Office. (2022). Espacenet Patent Search.
[3] World Intellectual Property Organization. (2021). Patent Landscape Reports.
[4] USPTO. (2022). Patent Application Publications.
[5] Litman, R. (2020). Pharmaceutical Patent Strategies. Journal of Intellectual Property Law.
